CADPX | VIHAX | CADPX / VIHAX | |
Total Expense Ratio | 0.80 | 0.17 | 471% |
Annual Report Gross Expense Ratio | 0.88 | 0.17 | 518% |
Fund Existence | 12 years | 10 years | - |
Gain YTD | 25.747 | 25.865 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 598M | 13.4B | 4% |
Annual Yield % from dividends | 2.89 | 3.95 | 73% |
Returns for 1 year | 13.19 | 18.56 | 71% |
Returns for 3 years | 64.75 | 63.45 | 102% |
Returns for 5 years | 47.71 | 69.66 | 68% |
Returns for 10 years | 62.72 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QTOP | 31.31 | 0.22 | +0.71% |
iShares Nasdaq Top 30 Stocks ETF | |||
EQWL | 114.93 | 0.80 | +0.70% |
Invesco S&P 100 Equal Weight ETF | |||
LABD | 32.34 | 0.16 | +0.50% |
Direxion Daily S&P Biotech Bear 3X ETF | |||
BSJT | 21.54 | 0.04 | +0.19% |
Invesco BulletShares 2029 HY Corp Bd ETF | |||
ANEW | 51.26 | N/A | N/A |
ProShares MSCI Trnsfmtnl Chngs ETF |